A Summary of the Consensus for the Management of Thyroid Disorders in Malaysia

Authors

  • Suehazlyn Zainudin Faculty of Medicine, National University Malaysia, Kuala Lumpur, Malaysia
  • Zanariah Hussein Putrajaya Hospital, Putrajaya, Malaysia
  • Mohammad Yazid Jalaludin Faculty of Medicine, University Malaya Medical Centre, Petaling Jaya, Malaysia
  • Wong Ming Faculty of Medicine, National University Malaysia, Kuala Lumpur, Malaysia
  • Lim Shueh Lin Penang General Hospital, Penang, Malaysia
  • Malik Mumtaz Island Hospital, Penang, Malaysia
  • Rokiah Pendek Faculty of Medicine, University Malaya Medical Centre, Petaling Jaya, Malaysia
  • Mafauzy Mohamed School of Health Sciences, Hospital Universiti Sains Malaysia, Kota Baru, Kelantan, Malaysia
  • Amir Khir Penang Medical College, Penang, Malaysia

Abstract

Thyroid disorders are amongst one of the most common endocrine diseases in Malaysia. In 1998, a taskforce consisting of experts in the field of thyroidology was set up to develop consensus recommendations for the management of thyroid disorders in the country based on available scientific evidence at that point in time. The following article summarizes the recommendations put together by the task force incorporating some of the recent available evidence with regards to the treatment of thyroid disorders.

Downloads

Download data is not yet available.

References

Trzepacz PT, Klein I, Roberts M, et al. Graves’ disease; An analysis of thyroid hormone levels and hyperthyroid signs and symptoms.Am J Med.1989;87:558-561

Abraham-Nording M, Torring O, Hamberger B, et al. Graves’ disease: A long-term quality-of-life follow up of patients randomized to treatment with antithyroid drugs, radioidine or surgery. Thyroid. 2005;15:1279-1286

Laurberg P, Buchholtz Hansen PE, Iversen E, et al. Goitre size and outcome of medical treatment of Graves’ disease. Acta Endocrinol (Copenh).1986;111:39-43

Amit Allahabadia, Daykin J, Sheppard MC, Gough SCL, Franklyn JA. Radioiodine treatment of hyperthyroidism-prognostic factors for outcome. J Clin Endocrinol Metab 2001; 86(8): 3611-3617

Meier DA. Procedure guidelines for therapy of thyroid disease with iodine-131 (Sodium Iodide) J Nucl Med 2002; 43; 856-861

Torring O, Tallstedt L, Wallin G et al. The Thyroid Study Group Graves’ hyperthyroidism: Treatment with antithyroid drugs, surgery, or radioiodine-a prospective, randomized study. J Clin Endocrinol Metab 1996; 81:2986–2993

Perros P, Kendall-Taylor P, Neoh C, Frewin S, Dickinson J. A prospective study of the effects of radioiodine therapy for hyperthyroidism in patients with minimally active Graves’ Ophthalmopathy. J Clin Endocrinol Metab 2005; 90:5321–5323

Aizawa, Y, Yoshida, K, Kaise, N, et al. The development of transient hypothyroidism after iodine-131 treatment in hyperthyroid patients with Graves' disease: Prevalence, mechanism and prognosis. Clin Endocrinol 1997; 46:1.

Zang S, Ponto KA, Kahaly GJ .Intravenous glucocorticoids for Graves’ orbitopathy: Efficacy and morbidity J Clin Endocrinol Metab.2011.96:320-332.

Bartalena L, Pinchera A, Marcocci C. Management of Graves’ ophthalmopathy: Reality and perspective. Endo Reviews.2000. 21:168-199.

Burch HB, Wartofsky L. Life-threatening thyrotoxicosis. Thyroid storm. Endocrinol Metab Clin North Am. Jun 1993;22(2):263-77

Tunbridge WMG, Evered DC, Hall R, et al. The spectrum of thyroid disease in a community: The Whickham Survey. Clin Endocrinol (Oxf ). 1977. 7:481–493.

Mazzaferri EL. Management of a solitary thyroid nodule. N Engl J Med. 1993.328:553–559.

Carmeci C, Jeffrey RB, McDougall IR, Nowels KW, Weigel RJ. Ultrasound-guided fine-needle aspiration biopsy of thyroid masses.1998. Thyroid 8:283–289

Downloads

Published

2014-05-21

How to Cite

Zainudin, S., Hussein, Z., Jalaludin, M. Y., Ming, W., Lin, L. S., Mumtaz, M., … Khir, A. (2014). A Summary of the Consensus for the Management of Thyroid Disorders in Malaysia. Journal of the ASEAN Federation of Endocrine Societies, 27(1), 40. Retrieved from https://asean-endocrinejournal.org/index.php/JAFES/article/view/11

Issue

Vol. 27 No. 1 (2012): May Issue

Section

Feature Articles

License

Journal of the ASEAN Federation of Endocrine Societies is licensed under a Creative Commons Attribution-NonCommercial 4.0 International. (full license at this link: http://creativecommons.org/licenses/by-nc/3.0/legalcode).

To obtain permission to translate/reproduce or download articles or use images FOR COMMERCIAL REUSE/BUSINESS PURPOSES from the Journal of the ASEAN Federation of Endocrine Societies, kindly fill in the Permission Request for Use of Copyrighted Material and return as PDF file to jafes@asia.com or jafes.editor@gmail.com.

A written agreement shall be emailed to the requester should permission be granted.

Most read articles by the same author(s)

1 2 3 4 > >>